English | Español

Boehringer-Ingelheim
Jamie Barrand | Oct 7, 2015

Boehringer Ingelheim, BioMed X establish joint research team
Daniel Daw | Sep 18, 2015

Study shows Jardiance reduces cardiovascular risks in patients with Type 2 diabetes
Jamie Barrand | Sep 18, 2015

Spriva Respimat approved by FDA for maintenance treatment of asthma

Trending
+ Regulatory
C.D. Marsden | Apr 12, 2025

Empower Pharmacy: Eli Lilly lawsuit is ‘Big Pharma’s attempt to limit patient and provider choice’
+ Community
Patient Daily | Apr 17, 2025

ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+ Pharmaceuticals
Patient Daily | Apr 15, 2025

UCSF neurosurgeon: '340B is a drug discount program that hospitals exploit as an additional revenue stream'
+ Pharmaceuticals
Patient Daily | Apr 15, 2025

President of Drug Channels Institute: 'Hospital prices are significantly higher at large 340B hospitals'